Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Profound Medical Corp. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of PROF: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders6357−6
Shares16.1M16.3M+280.5K (+1.7%)
Value$126.3M$105.6M−$20.7M (−16.4%)

New holders (10)

Institutions that held Profound Medical Corp. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to PROF in Q1 2026
InstitutionSharesValue% of portfolio
Lagoda Investment Management, L.P.441,015$2.86M1.76%
Paragon Associates & Paragon Associates II Joint Venture276,001$1.79M2.43%
Annis Gardner Whiting Capital Advisors, LLC40,000$259.2K0.04%
Jane Street Group, LLC36,687$237.7K0.00%
HB Wealth Management, LLC30,000$194.4K0.00%
Centiva Capital, LP29,280$189.7K0.01%
Penbrook Management LLC12,300$79.7K0.06%
Captrust Financial Advisors10,398$67.4K0.00%
Caitong International Asset Management Co., Ltd96$6220.00%
North Star Investment Management Corp.58$3760.00%

Sold out (16)

Institutions that held Profound Medical Corp. at the end of Q4 2025 and filed for Q1 2026 without it.